Tag: Atossa Therapeutics Inc (NASDAQ: ATOS)

Business

Vistagen Therapeutics Inc (NASDAQ: VTGN), Atossa Therapeutics Inc (NASDAQ: ATOS), eMagin, And Kopin Set To Be Added In The Russell 2000 Index

Vistagen Therapeutics Inc (NASDAQ: VTGN) will be included in the Russell Index with effect from June 28, 2021. The stock trades at $2.80 (up 1.08%) on June 16, 2021. Vistagen gained 24.44% in one month. It is a small-cap stock. Investors may exit this stock at the current levels and […]

Business

Dr. Steven Quay Of Atossa Therapeutics Inc (NASDAQ: ATOS) Will Discuss Phase 2 Clinical Trial Data Of Endoxifen In Patients With Breast Cancer Before Surgery At A Webinar On June 9, 2021

Atossa Therapeutics Inc (NASDAQ: ATOS)’s CEO, Steven Quay, will discuss and release Phase 2 trial final data of Endoxifen examined in breast cancer patients before surgery at a webinar on June 9, 2021. Other key executives to attend this webinar are its VP (Clinical, CMC, and Regulatory) – B. Heather […]